Zobrazeno 1 - 10
of 774
pro vyhledávání: '"Gascoyne, RD"'
Autor:
Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD, Greiner TC, Smith L, Guo S, Wilcox RA, Teh BT, Lim ST, Tan SY, Rimsza LM, Jaffe ES, Campo E, Martinez A, Delabie J, Braziel RM, Cook JR, Tubbs RR, Ott G, Geissinger E, Gaulard P, PICCALUGA P., Pileri SA, Au WY, Nakamura S, Seto M, Berger F, de Leval L, Connors JM, Armitage J, Vose J, Chan WC, Staudt LM, Lymphoma Leukemia Molecular Profiling Project, the International Peripheral T. cell Lymphoma Project
Publikováno v:
Blood. 123(19)
Peripheral T-cell lymphoma (PTCL) encompasses a heterogeneous group of neoplasms with generally poor clinical outcome. Currently 50% of PTCL cases are not classifiable: PTCL-not otherwise specified (NOS). Gene-expression profiles on 372 PTCL cases we
Autor:
Choi, WWL, Weisenburger, DD, Greiner, TC, Piris, MA, Banham, AH, Jaye, DL, Wade, PA, Iqbal, J, Hans, CP, Fu, K, Gascoyne, RD, Delabie, J, Rosenwald, A, Rimsza, L, Campo, E, Jaffe, ES, Staudt, LM, Chan, WC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3645325df8669610ccaff21f785b68e9
https://ora.ox.ac.uk/objects/uuid:78f85be2-40fe-4d9e-b4ce-a0488598483b
https://ora.ox.ac.uk/objects/uuid:78f85be2-40fe-4d9e-b4ce-a0488598483b
Autor:
Jean Powers, Fernandez La, Elizabeth Eisenhauer, Sarit Assouline, Robert Turner, Michael Crump, Neil Chua, Wendy Walsh, Kouroukis Ct, Rena Buckstein, Richard Klasa, Gascoyne Rd
Publikováno v:
Leukemia & Lymphoma. 52:394-399
Bortezomib and gemcitabine have each shown activity as single agents in mantle cell lymphoma (MCL), which is incurable. The purpose of this phase II study was to determine the efficacy and safety of the previously unstudied combination of bortezomib
Autor:
Hartmann S, Tousseyn T, Döring C, Flüchter P, Hackstein H, Herreman A, de Wolf Peeters C, Facchetti F, Gascoyne RD, Küppers R, Steidl C, Hansmann ML, PONZONI , MAURILIO
Publikováno v:
International journal of cancer. 133(11)
Abundant macrophage infiltration in tumors often correlates with a poor prognosis. T cell/histiocyte rich large B cell lymphoma (THRLBCL) is a distinct aggressive B cell lymphoma entity showing a high macrophage content. To further elucidate the role
Autor:
Suzumiya J, Ohshima K, Tamura K, Karube K, Uike N, Tobinai K, Gascoyne RD, Vose JM, Armitage JO, Weisenburger DD, for the International Peripheral T. Cell Lymphoma Project [Savage K, Connors J, Gascoyne R, Chhanabhai M, Wilson W, Jaffe E, Armitage J, Vose J, Weisenburger D, Anderson J, Ullrich F, Bast M, Hochberg E, Harris N, Levine A, Nathwani B, Miller T, Rimsza L, Montserrat E, Lopez Guillermo A, Campo E, Cuadros M, Alvarez Ferreira J, Martinez Delgado B, Holte H, Delabie J, Rüdiger T, Müller Hermelink K, Reimer P, Adam P, Wilhelm M, Schmitz N, Nerl C, MacLennan KA, Federico M, Bellei M, Coiffier B, Berger F, Tanin I, Wannakrairot P, Au W, Liang R, Loong F, Rajan S, Sng I, Matsuno Y, Morishima Y, Nakamura S, Seto M, Tanimoto M, Yoshino T, Kim WS, Ko Y.H. ], ZINZANI, PIER LUIGI, PILERI, STEFANO
Background: The International Peripheral T-cell Lymphoma Project was organized to better understand the T-cell and natural killer (NK) cell lymphomas, and our task is to present the clinicopathologic correlations and therapeutic results for adult T-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44cefa6a20199fa7260dc1f3a34e0df7
http://hdl.handle.net/11585/119626
http://hdl.handle.net/11585/119626
Autor:
Cheson, Bd, Pfistner, B, Juweid, Me, Gascoyne, Rd, Specht, L, Horning, Sj, Coiffier, B, Fisher, Ri, Hagenbeek, A, Zucca, E, Rosen, St, Stroobants, S, Lister, Ta, Hoppe, Rt, Dreyling, M, Tobinai, K, Vose, Jm, Connors, Jm, Federico, Massimo, Diehl, V, THE INTERNATIONAL HARMONIZATION PROJECT ON LYMPHOMA
Publikováno v:
Journal of clinical oncology, 25(5), 579-586. American Society of Clinical Oncology
Purpose Standardized response criteria are needed to interpret and compare clinical trials and for approval of new therapeutic agents by regulatory agencies. Methods The International Working Group response criteria (Cheson et al, J Clin Oncol 17:124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11fddcc1ab021d99097ea979553414f9
https://hdl.handle.net/11380/584203
https://hdl.handle.net/11380/584203
Autor:
Pileri, SA, Grogan, TM, Harris, NL, Banks, P, Campo, E, Chan, JK, Favera, RD, Delsol, G, De Wolf-Peeters, C, Falini, B, Gascoyne, RD, Gaulard, P, Gatter, KC, Isaacson, PG, Jaffe, ES, Kluin, P, Knowles, DM, Mason, DY, Mori, S, Müller-Hermelink, HK, Piris, MA, Ralfkiaer, E, Stein, H, Su, IJ, Warnke, RA, Weiss, LM
Publikováno v:
Histopathology. 41(1)
Neoplasms of histiocytes and dendritic cells are rare, and their phenotypic and biological definition is incomplete. Seeking to identify antigens detectable in paraffin-embedded sections that might allow a more complete, rational immunophenotypic cla
Autor:
Rudiger, T, Jaffe, ES, Delsol, G, deWolf-Peeters, C, Gascoyne, RD, Georgii, A, Harris, NL, Kadin, ME, MacLennan, KA, Poppema, S, Stein, H, Weiss, LE, Muller-Hermelink, HK
Publikováno v:
Annals of Oncology, 9, 31-38. Oxford University Press
Despite advances in immunohistochemistry and molecular biology, the distinction between classical Hodgkin's lymphoma and related diseases such as nodular lymphocyte-predominant Hodgkin's disease, T-cell rich large B-cell lymphoma or anaplastic large
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::2d0b2fff05a4e61b3a04466fdfc4d21f
https://research.rug.nl/en/publications/7742cbca-51e5-42ab-a3e9-a4b9f6d35935
https://research.rug.nl/en/publications/7742cbca-51e5-42ab-a3e9-a4b9f6d35935
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.